Editor of Patient Care Online.
Shared Decision-Making in Lung Cancer Screening: A Collaborative Approach
ACP 2025: Kim Sandler, MD, explains how primary care physicians can use shared decision-making to guide patients through lung cancer screening, emphasizing risk, benefit, follow-up, and smoking cessation.
Benefits of Lung Cancer Screening: A Conversation with Kim Sandler, MD
ACP 2025: Kim Sandler, MD, sat down with Patient Care to discuss the benefits of lung cancer screening, citing a 20% reduction in lung cancer mortality with annual screenings.
FDA Approves Gepotidacin for Treatment of Uncomplicated UTIs: Daily Dose
Your daily dose of the clinical news you may have missed.
Switching to Tirzepatide Outweighs Escalating Dulaglutide Dose in T2D: SURPASS-SWITCH Trial
Breaking research presented at ACP Internal Medicine 2025 showed that switching GLP1-RAs resulted in better glucose and weight control among adults with inadequately controlled T2D.
Lung Cancer Screening: A Missed Opportunity for Early Detection
ACP 2025: Kim Sandler, MD, discussed the latest screening guidelines, real-world challenges in implementation, and the essential role of shared decision-making.
Universal Syphilis Screening in the ED Outperforms Targeted Approaches: Daily Dose
Alopecia Management in Primary Care: Expert Insights from ACP 2025
William Lewis, MD, discussed the importance of photo-documentation, referral indicators, efficacy of various treatments, and other topics.
ACP: Invest in Rural Communities to Decrease Health Disparities, Improve Access to Care
In a new position paper, the ACP calls for policy action to address rural health disparities, improve access to care, and strengthen the rural health care workforce.
Responsive Parenting Intervention Curbs Childhood Obesity Risk: Daily Dose
Osteoporosis Screening Misses Younger Postmenopausal Women: Daily Dose
ACC 2025: Cardiovascular Benefits of Semaglutide 2.4 mg Highlighted in Real-World Study
Semaglutide 2.4 mg significantly lowered the risk of MACE and mortality in patients with ASCVD and overweight or obesity but without diabetes, researchers reported.
Expert Insights: Q&A with Mark Ebell, MD, on Gepotidacin and UTI Management
Family physician and researcher Mark Ebell, MD, discusses the clinical implications, efficacy, and role of gepotidacin in UTI management.
Uneven US Cancer Screening Recovery Post-COVID: Daily Dose
FDA Authorizes Marketing of First At-Home Test for Chlamydia, Gonorrhea, Trichomoniasis
The Women’s Sexual Health Test (Visby Medical) delivers results in approximately 30 minutes using a vaginal swab.
CagriSema Achieves Significant Weight Loss in Phase 3 Trial: Daily Dose
New Study Suggests Bacterial Vaginosis May be Sexually Transmitted
New research shows that treating both men and women with topical and oral antibiotics lowers the odds of bacterial vaginosis recurrence by more than half.
Cleveland Clinic Researchers Develop Risk-Prediction Model for Early-Onset Colorectal Cancer in Young Adults
The model identified BMI, tobacco use, and family history of CRC as the strongest predictors for advanced neoplasia in young adults.
Omalizumab Beats OIT in First Head-to-Head Multi-Food Allergy Trial: Daily Dose
April Issue of Patient Care Digital Edition is Now Live
The April issue covers atopic dermatitis, highlighting primary care’s role in early diagnosis, key updates from recent conferences, and more.
Decline in Smoking Averted Nearly 4 Million Lung Cancer Deaths in the US, Study Estimates
The number of lung cancer deaths averted represents more than 51% of the expected reduction in total cancer deaths, researchers reported.
Better CV Health Tied to Lower Neurodegeneration Risk: Daily Dose
Underutilization of Guideline-Recommended Epinephrine in Anaphylaxis Management: New Study
A 5-year study conducted in Germany showed only 7% of adults and 8% of children with severe anaphylaxis received epinephrine.
Sanofi's Chlamydia Vaccine Granted FDA Fast Track Designation
The FDA granted fast track designation to Sanofi’s chlamydia vaccine candidate today, aiming to prevent infections and address an unmet public health need.
Delgocitinib Cream Shows "Super Response" in Chronic Hand Eczema: Daily Dose
FDA Approves Gepotidacin (Blujepa) for Treatment of Uncomplicated UTIs
Gepotidacin is the first new oral antibiotic for uncomplicated urinary tract infections in 30 years, offering an alternative amid rising antibiotic resistance.
Maternal Mortality Due to Cardiovascular Disease More Than Doubles in the US
ACC 2025: Black women and women in Southern states faced significantly higher rates of maternal mortality, according to a new study.
OX40 Inhibitor Rocatinlimab Found Effective for Atopic Dermatitis: Daily Dose
Deadline Intervention Boosts Colorectal Cancer Screening Uptake: New Study
Adding a deadline to a mailed invitation for FIT colorectal cancer screening resulted in improved return rates, according to new research.
Omlyclo Gains FDA Approval as Interchangeable Omalizumab Biosimilar: Daily Dose
Marijuana Use Tied to Increased Risk for Myocardial Infarction in People Aged 50 Years and Younger
Cannabis users had a more than sixfold increased risk of MI compared to non-users, according to a new study.
